Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort
Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort. // Endocrine Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1530891X26012863?dgcid=rss_sd_all
Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort. Endocrine Practice. https://www.sciencedirect.com/science/article/pii/S1530891X26012863?dgcid=rss_sd_all
“Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort.” Endocrine Practice.
@article{article89147,
title = {Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort},
journal = {Endocrine Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1530891X26012863?dgcid=rss_sd_all}
}